【レポートの概要（一部）】
Table of Content
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Gout Therapeutics Market Variables, Trends & Scope
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Introduction of urate-lowering agents
3.1.1.2 Rising prevalence of gout
3.1.2 Market restraint analysis
3.1.2.1 Competition from generic drugs
3.1.2.2 High cost of recently launched drugs
3.2 Penetration & Growth Prospects Mapping
3.3 Gout Therapeutics Market – PESTLE Analysis
3.4 Industry Analysis – Porter’s
3.5 Gout Therapeutics Competitive Scenario
3.5.1 Competitive landscape: Market position analysis (based on product portfolio, regional presence and strategic initiatives)
Chapter 4 Gout Therapeutics: Drug Class Estimates & Trend Analysis
4.1 Global Gout Therapeutics Market: Drug Class Movement Analysis
4.2 NSAIDs
4.2.1 NSAIDs market estimates and forecasts, 2014 – 2025 (USD Million)
4.3 Corticosteroids
4.3.1 Corticosteroids market estimates and forecasts, 2014 – 2025 (USD Million)
4.4 Colchicine
4.4.1 Colchicine market estimates and forecasts, 2014 – 2025 (USD Million)
4.5 Urate-Lowering Agents
4.5.1 Urate-lowering agents market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 5 Gout Therapeutics: Disease Condition Estimates & Trend Analysis
5.1 Global Gout Therapeutics Market: Disease Condition Movement Analysis
5.2 Acute Gout
5.2.1 Acute market estimates and forecasts, 2014 – 2025 (USD Million)
5.3 Chronic Gout
5.3.1 Chronic gout market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 6 Gout Therapeutics: Regional Estimates & Trend Analysis
6.1 Regional Movement Analysis & Market Share, 2015 & 2025
6.2 North America
6.2.1 North America gout therapeutics market, by drug class, 2014 – 2025 (USD Million)
6.2.2 North America gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.2.3 U.S.
6.2.3.1 U.S. gout therapeutics market, by drug class, 2014 – 2025 (USD Million)
6.2.3.2 U.S. gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.2.4 Canada
6.2.4.1 Canada gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.2.4.2 Canadagout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.3 Europe
6.3.1 Europe gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.3.2 Europe gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.3.3 Germany
6.3.3.1 Germany gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.3.3.2 Germanygout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.3.4 UK
6.3.4.1 UK gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.3.4.2 UK gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.4.2 Asia Pacific gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.4.3 Japan
6.4.3.1 Japan gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.4.3.2 Japan gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.4.5 China
6.4.5.1 China gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.4.5.2 China gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.5 Latin America
6.5.1 Latin America gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.5.2 Latin America gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.5.3 Brazil
6.5.3.1 Brazil gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.5.3.2 Brazilgout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexicogout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.5.4.2 Mexicogout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.6 MEA
6.6.1 MEA gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.6.2 MEA gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.6.3 South Africa
6.6.3.1 South Africa gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.6.3.2 South Africagout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Takeda Pharmaceutical Company Ltd.
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 Novartis
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 Savient Pharmaceuticals
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Regeneron Pharmaceuticals
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 AstraZeneca plc
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 Horizon Pharma plc
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic Initiatives
7.7 Boehringer Ingelheim
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 Merck & Co. Inc
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 Teijin Pharma Ltd
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic initiatives
7.10 GlaxoSmithKline plc
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic initiatives
【レポート販売概要】
■ タイトル：痛風治療薬の世界市場分析：薬の種類別（非ステロイド性抗炎症薬[NSAIDs]、コルチコステロイド、コルヒチン、尿酸塩低下薬）、病気の状態別（急性痛風、慢性痛風）、セグメント予測、2014-2025■ 英文：Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory Drugs [NSAIDs], Corticosteroids, Colchicine, Urate-Lowering Agents), By Disease Condition (Acute Gout, Chronic Gout), And Segment Forecasts, 2014-2025
■ 発行日：2017年3月7日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707374
■ 調査対象地域：グローバル
- Hemostasis：グローバル臨床試験レビューH2, 2013Hemostasis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H2, 2013" provides data on the Hemostasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemostasis. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- 2014年戦略提言：イギリスの病院内感染症検査市場This new report from Venture Planning Group contains 886 pages, 67 tables, and presents a comprehensive analysis of the UK hospital infectious disease testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current …
- DaaS（クラウド型データサービス）の世界市場2016-2020About the Data As A Service (DaaS) Market DaaS is a cloud computing service model that refers to the sourcing, management, and provisioning of data in a consumable format to business users over the Internet. It facilitates the delivery of specified data to users on-demand, regardless of any geographical or organizational separation between providers and consumers. The DaaS model transfers the burd …
- 動物用画像診断装置の世界市場予測（～2022年）：超音波、X線、MRI、ビデオ内視鏡The global veterinary imaging market is estimated to grow at a CAGR of 6.8% from 2017 to 2022, to reach USD 1.94 billion by 2022 from USD 1.40 billion in 2017. The growth of the veterinary imaging market during the forecast period is mainly driven by the increase in animal healthcare spending and growing pet insurance purchase, the growing companion animals market, increase in the number of veteri …
- 世界の分子診断市場：感染症検査、癌検査、血液検査、遺伝子検査Molecular Diagnostics (MDx) – your guide to technologies, trends and revenues Where is the molecular diagnostics market heading? Visiongain’s new report gives you revenue predictions for the molecular diagnostics market and its submarkets from 2014, helping you stay ahead. The 173-page report provides 134 tables, charts, and graphs. Discover the growing trends of this industry. In particular, our …
- Rock Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Rock Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Rock Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
- ホットメルト接着剤の世界市場：EVA、SBC、APAO、POE、PUThe global hot melt adhesive market size, in terms of value, is projected to reach USD 9.64 Billion by 2020, at a CAGR of 5.73% between 2015 and 2020. The high-growth application areas such as construction, packaging and labeling, woodworking, transportation, footwear, automotive, and continuous new product launch and expansion activities undertaken by companies are key factors driving the growth …
- 世界のパワートレインコントロールモジュール(PCM)市場2015The Global Powertrain Control Module (PCM) Industry Report 2015 is a professional and in-depth study on the current state of the Powertrain Control Module (PCM) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Powertrain Control Module (PCM) market analysis is provided for the international markets …
- 増殖性硝子体網膜症(Proliferative Vitreoretinopathy (PVR))の治療薬パイプライン動向（2015年上半期版）Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2015’, provides an overview of the Proliferative Vitreoretinopathy (PVR)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Proliferative Vitreoretinopathy (PVR), complete with comparati …
- 3Dレンダリングサービスの世界市場：サービス別（インテリアの視覚化、エクステリアの視覚化、モデリングサービス、ウォークスルーとアニメーション、フロアプラン）、エンドユーザー別（建築家、デザイナー、エンジニアリング会社、不動産会社）、プロジェクトタイプ別（商業プロジェクト、住宅プロジェクト）3D rendering is an integrated service that is used for graphical representation and advanced rendering. The solution is used for processing 3D pictures that are stored in the systems to draw realistic lighting, textures, shadow, colors, and others. 3D rendering has been used by different industry verticals such as media & entertainment, construction & real estate, energy & utility, education, and …
- 世界のトップ10高成長複合材料市場“The top 10 high growth composite materials market is projected to grow at a CAGR of 7.04% during forecast period”The top 10 high growth composite materials market is projected to reach USD 69.50 billion in 2015 to USD 105.26 billion by 2021, at a CAGR of 7.04% between 2016 and 2021. The major factor expected to boost the growth of the market is high demand for top 10 composite materials from the …
- Legacy Oil + Gas Inc.：石油・ガスバリューチェーン分析レポート2013Legacy Oil + Gas Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Legacy Oil + Gas Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Legacy Oil + Gas Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report e …
- 5G装置の世界市場2016-2020About 5G 5G mobile wireless technology is the key component of a connected society. The aim of 5G is to provide ubiquitous connectivity to all connected devices and connected applications. 5G enables real-time and reliable communication for mission-critical applications. 5G wireless technology evolution requires several relevant components such as backhaul integration, device-to-device communicati …
- アメリカの血漿交換療法（TPE）市場予測（～2021）The U.S. therapeutic plasma exchange (TPE) market by indication is estimated to reach USD 260.0 Million by 2021, growing at a CAGR of 11% to 12% during the forecast period. The growing prevalence of neurological diseases; increasing adoption of TPE procedures in rare disorders such as Guillain-Barré syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Neuromylitis Optica, Thro …
- 炭酸アンモニウムの世界市場2019-2023About this market Increase in R&D activities to drive market growth. The increase in investments and technological advances in the ammonia industry are expected to drive the demand for ammonium carbonate. Technological improvements such as Haber-Bosch process improvements, catalysts and absorbents selection, and new electrochemical processes are used in the production of ammonia. Such advanced tec …
